Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly men
Introduction
Recent studies showed that hyperuricemia (HUC) was closely related to metabolic syndrome (MS) and each of its components (Xuemei et al., 2008), and patients with HUC have poor cardiovascular outcomes (Kawamoto et al., 2006). Sautin and Johnson (2008) proposed the oxidant-antioxidant paradox of uric acid, which acts as a pro-oxidant primarily within the cell and as an anti-oxidant primarily in plasma. A high prevalence of HUC, which has been reported in elderly Taiwanese (46% for males and 26% for females), is significantly associated with the MS (Lee et al., 2005). A recent study also showed that an increased serum uric acid concentration was associated with a high prevalence of metabolic disorders such as obesity, dyslipidemia, and hypertension in the Chinese population (Cai et al., 2009). The results of recent studies suggested that HUC should be treated as a major metabolic abnormality and should be included in the definition of the MS (Lin et al., 2008). In contrast, Puig et al. (2008) claimed that HUC was simply a marker of the MS rather than a target to treat. Therefore, there continues to be uncertainty whether serum uric acid levels parallel the MS in the elderly, particularly males. The role of HUC in the pathogenesis of the MS remains unclear. In addition, the enrolled populations of previous studies were heterogeneous in race, age, and gender. In the present study, we attempted to investigate the association of HUC with the components of the MS and inflammatory markers in institutionalized elderly men in Taiwan.
Section snippets
Study participants
A total of 333 residents of the Chang-Hua Veterans Care Home, Taiwan, were enrolled from July 1 to August 31, 2002. The clinical demographic information, health profiles, and biochemical data were collected through formal administrative procedures and health examinations, including questionnaires, self-reported illnesses, and physical checkups. The Institutional Review Board of Taichung Veterans General Hospital reviewed and approved the study. All participants gave their written informed
Clinical features of the subjects with HUC and with normouricemia (NUC)
In total, 333 elderly men (mean age = 78.6±3.9 years; range, 70–91 years) were enrolled (Table 1). Serum uric acid levels were 6.9±1.7 mg/dl (range, 2.0–13.2 mg/dl). Overall, 154 (46.2%) subjects had HUC, and 128 (38.4%) had the MS. Subjects with HUC had greater WC (91.3±9.6 cm vs. 87.2±8.8 cm, p < 0.001), higher BMI (24.7±3.5 kg/m2 vs. 23.4±3.4 kg/m2, p = 0.002), higher TG (113.1±68.1 mg/dl vs. 89.5±49.7 mg/dl, p < 0.001), and lower HDLC (45.1±12.0 mg/dl vs. 48.9±12.8 mg/dl, p = 0.004) levels.
Discussion
A recent study showed that HUC might be a risk factor for cardiovascular events (Chien et al., 2005), and a positive correlation between uric acid level and carotid intima-thickness was seen in patients with hypertension (Tavil et al., 2008). Significant associations of HUC with visceral or central obesity, high BMI, high waist-hip ratio, and vascular endothelial dysfunction were also reported (Lee et al., 2005; Lin et al., 2007). Saggiani et al. (1996) reported that the major predictors of
Conclusions
The serum uric acid level in elderly institutionalized men was significantly correlated with impaired renal function, high body fat composition, high BMI, and high serum prealbumin level. Higher serum PAI-1 levels were found in subjects with HUC than in those without HUC, although the difference was not significant. There were no significant differences in CRP, IL-6, TNF-α, sICAM-1, sVCAM-1, and P-selectin levels between subjects with HUC and those without HUC. The association of HUC with the
Acknowledgements
The authors are grateful to the Biostatistics Task Force of Taichung Veterans General Hospital, Taichung, Taiwan, ROC for providing statistical analysis for this study.
Conflict of interest statement
The authors have no conflicts of interest to report.
References (18)
- et al.
Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study
Atherosclerosis
(2005) - et al.
Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid
Metab. Clin. Exp.
(2007) - et al.
The cardiovascular risk factor plasminogen activator inhibitor Type 1 is related to insulin resistance
Metabolism
(1993) - et al.
Serum uric acid and related factors in 500 hospitalized subjects
Metabolism.
(1996) - et al.
Uric acid level and its association with carotid intima–media thickness in patients with hypertension
Atherosclerosis.
(2008) - et al.
Correlation between blood fibrinolytic activity, PA-inhibitor level, plasma insulin level and relative body weight in normal and obese subjects
Metabolism
(1986) - et al.
Hyperuricemia and the metabolic syndrome in Hangzhou
Asia Pac. J. Clin. Nutr.
(2009) - et al.
Uric acid and cardiovascular risk
N. Engl. J. Med.
(2008) - et al.
Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas cohort
Arterioscler. Thromb. Vasc. Biol.
(1998)